Shares in German defence giant Rheinmetall (ETR: RHMG) tumbled 13% on Thursday—leading decliners across the pan-European STOXX 600—after management trimmed full-year sales and margin targets for the second time in three months. While demand from European rearmament remains at record highs, delayed procurement awards and execution bottlenecks have intensified scrutiny over conversion timelines.
📌 Guidance Downgrades & Valuation Metrics:
• 2026 Sales Target Reduced: Cut to ~€13.2 billion ($14.9B) from a prior range of €13.7B–€14.2B. • Margin Compression: Operating margin guidance lowered to ~18.5% (down from ~19.0%).
• Cash Conversion Target Dropped: Management withdrew its target for an operating cash conversion rate above 40%.
📌 Core Catalysts Behind the Downgrade:
• Arminius Boxer Contract Slippage: Revenue and advance payments linked to Germany’s Arminius Boxer wheeled armoured vehicle program—expected to generate >€3 billion in advance payments and ~€12.4 billion in initial contract volume—have shifted into 2027.
• Ammunition Bottlenecks: Slower regulatory batch approvals delayed high-margin artillery ammunition deliveries.
• Delayed Venture Milestones: Anticipated revenue from newer initiatives, including its tactical partnership with Dutch missile/drone developer Destinus, will not fully materialize this year.
📌 Q3 Financials vs. Underlying Execution Risks:
• Top-Line & Earnings Beat: Third-quarter revenue surged 32% YoY to €3.15 billion, while operating profit jumped 62% to €553 million.
• Negative Cash Flow & Soft Intake: Despite headline profitability, Q3 order intake came in at €2.89 billion (trailing sales of €3.15B) and operating free cash flow fell into the red at negative €82 million.
💡 Market Takeaway: Surging geopolitical demand and record defence order backlogs are not enough on their own. Institutional allocators are shifting focus from headline order intake to execution velocity, working capital management, and free cash flow conversion.